Geron (GERN) Stock
Geron (GERN) closed at $1.00 on Nov 17, 2026; its Tenet Score is 55 of 100 against 340 Healthcare peers.
21 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $1.00
- Nov 17, 2026
- Market cap
- $606.8M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 0.84 – 2.01
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 55/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Geron Corp. scores 55/100. Mixed. Strongest on value, quality is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, whi…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Annexon IncANNX | 37 | $733.7M |
| Universe Pharmaceuticals INCUPC | 62 | $674.7M |
| Janux Therapeutics IncJANX | 74 | $668.1M |
| Kura Oncology IncKURA | 30 | $651.4M |
| Olema Oncology Inc.OLMA | 56 | $644.8M |
| Arbutus Biopharma CorpABUS | 58 | $619.3M |
| Cullinan Therapeutics IncCGEM | 55 | $616.7M |
| Climb Bio Inc.CLYM | 62 | $583.9M |
| Wave Life Sciences Inc.WVE | 54 | $566.0M |
| Sana Biotechnology IncSANA | 36 | $563.3M |
Common questions
What sector and industry is Geron in?
Geron is in the Healthcare sector and the Drugs industry.
What is Geron's Tenet Score?
Geron's Tenet Score is 55 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




